Abstract
An understanding of the gross anatomic relationship of the prostate to other structures within the male pelvis is of great medical importance. Because benign prostatic hyperplasia and adenocarcinoma of the prostate are common conditions of aging men, a clear understanding of the anatomic relationships among the prostate, seminal vesicles, and bladder is important for developing the concepts necessary to understand the clinical aspects and management of early stage prostate cancer.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Laurenson RD: An Introduction to Clinical Anatomy by Dissection of the Human 17. Body. Philadelphia: WB Saunders; 1968.
Greene DR, Shabsigh R, Scardino PT: Urologic ultrasonography. In Campbell’s 18. Urology, edn 6. Edited by Walsh PC, Retik AB, Stamey TA, Vaughan ED, Jr. Philadelphia: WB Saunders; 1992: 344–393.
Stamey TA, McNeal JE: Adenocarcinoma of the prostate. In Campbell’s Urology, 19. edn 6. Edited by Walsh PC, Retik AB, StameyTA, Vaughan ED, Jr. Philadelphia: WB Saunders; 1992: 1181.
Resnick MI, Older RA: Diagnosis of Genitourinary Disease, edn 2. New York: Thieme; 1997.
Tanagho EA: Physical examination of the genitourinary tract. Smith’s General Urology, edn 12. Edited by Tanagho EA, McAninch JW. Norwalk: Appleton and 21. Lange; 1988: 40–47.
Carter HB, Partin AW: Diagnosis and staging of prostate cancer. In Campbell’s 22. Urology, edn 7. Edited by Walsh PC, Retik AB, Wein Ai, Vaughan ED, Jr. Philadelphia: WB Saunders; 1998: 2522.
Beduschi MC, Oesterling JE: Prostate-specific antigen density. Urol Clin North 23. Am 1997, 24: 323–332.
Carter HB, Pearson JD, Metter JE, et al.: Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease. JAMA 1992, 267: 2215–2220.
Oesterling JE, Jacobson SJ, Chute CG, et al.: Serum prostate-specific antigen in a community-based population of healthy men: establishment of age-specific reference ranges. DAMA 1993, 270:860–864.
Morgan TO, Jacobson SJ, McCarthy WF, et al.: Age-specific reference ranges for serum prostate-specific antigen in black men. N Engl J Med 1996, 335: 304–310.
Partin AW: The clinical utility of prostate-specific antigen: critical issues for 1997. Advances in Prostate Cancer 1997: 2–4.
Stamey TA: Making the most out of six systematic sextant biopsies. Urology 1995, 45: 2–12.
Terris MK, McNeal JE, StameyTA, et al.: Detection of clinically significant prostate cancer by transrectal ultrasound-guided systematic biopsies. J Urol 1992, 148: 829–832.
Kirby RS, Christmas TJ, Brawer MJ: Prostate Cancer. Wilmington, DE: Zeneca Press; 1996: 82.
Partin AW: Issues in the Diagnosis and Prognosis of Prostate Cancer: A Slide Lecture Series. Oklahoma City: Cytodiagnostics (UROCOR ); 1995.
Prostate Cancer: Management of Advanced Disease. Wilmington, DE: ICI Pharmaceutical; 1995.
Jewett HJ: The present status of radical prostatectomy for stages A and B prostatic cancer. Urol Clin North Am 1975, 2: 105–124.
Gishman JR, de Vere White RW: Prostate cancer: screening, diagnosis, and staging. In Clinical Urology. Edited by Krane RJ, Siroky MB, Fitzpatrick JM. Philadelphia: JB Lippincott; 1994: 947–948.
Stamey TA, McNeal JE, Yemoto CM, et al.: Biological determinants of cancer progression in men with prostate cancer. DAMA 1999, 281:1395–1400.
Pan CC, Potter SR, Partin AW, et al.: The prognostic significance of tertiary Gleason patterns of higher grade in the radical prostatectomy specimens: a proposal to modify the Gleason grading system. Am J Surg Pathol 2000, 24:563–569.
Gleason D: Urologic Pathology: The Prostate. Edited by Tannenbaum M. Philadelphia: Lea & Febiger; 1997: 171–198.
Partin AW, Kaftan MW, Subong ENP, et al.: Combination of prostate-specific antigen, clinical stage and Gleason score to predict pathological stage of localized prostate cancer: a multi-institutional update. JAMA 1997; 277:1445–1451.
Using the Updated Partin Nomogram. Deerfield, IL: TAP Pharmaceuticals; 1997.
Graefen M, Karakiewicz PI, Cagiannos I, et al.: Validation study of the accuracy of a postoperative nomogram for recurrence after radical prostatectomy for localized prostate cancer. J Clin Oncol2002, 20: 951–956.
D’Amico AV, Whittington R, Malkowicz SB, et al.: Pretreatment nomogram for prostate-specific antigen recurrence after radical prostatectomy or external-beam radiation therapy for clinically localized prostatectomy or external-beam radiation therapy for clinically localized prostate cancer. J Clin Oncol 1999, 17: 168–172.
Bostwick DG: Issues in the Diagnosis and Prognosis of Prostate Cancer. Oklahoma City: Cytodiagnostics (UROCOR) Speaker Support Program; 1995.
Gpoalkrishnan RV, Kang DC, Fisher PB: Molecular markers and determinants of prostate cancer metastasis. J Cell Physiol 2001, 189: 245–256.
Humphrey PA, Keetch DW, Smith DS, et al.: Prospective characterization of pathological features of prostatic carcinomas detected via serum prostate-specific antigen based screening. J Urol 1996, 155:816–820.
Epstein JI, Walsh PC, Carmichael M, Brendler CB: Pathologic and clinical findings to predict tumor extent of non-palpable (stage Ti c) prostate cancer. JAMA 1994, 271: 368–374.
von Eschenbach A, Ho R, Murphy GP, et al.: American Cancer Society Guidelines for the early detection of prostate cancer. Cancer 1997, 80: 1805–1807.
National Center for Health Statistics, 1998: http//www.cdc.gov/nchs/default.htm. Accessed Sept. 16, 2002.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Current Medicine, Inc.
About this chapter
Cite this chapter
Ernstoff, M.S. (2003). Clinical Aspects of Prostate Cancer. In: Bruskewitz, R.C. (eds) Atlas of the Prostate. Current Medicine Group, London. https://doi.org/10.1007/978-1-4615-6505-5_8
Download citation
DOI: https://doi.org/10.1007/978-1-4615-6505-5_8
Publisher Name: Current Medicine Group, London
Print ISBN: 978-1-4615-6507-9
Online ISBN: 978-1-4615-6505-5
eBook Packages: Springer Book Archive